Barbara W. Bodem Syneos Health, Inc. (SYNH) insider trading activity

SYNH Quotes by TradingView

Barbara W. Bodem is Director of Syneos Health, Inc.. Currently has a direct ownership of 0 shares of SYNH, which is worth approximately $0. The most recent transaction as insider was on Sep 28, 2023, when has been sold 8,385 shares (Class A Common Stock) at a price of $21.5 per share, resulting in proceeds of $180,277. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Barbara W. Bodem Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 28 2023
SELL
Sale (or disposition) back to the issuer
$180,277 $21.5 p/Share
8,385 Reduced 100.0%
0 Class A Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
4,863 Added 36.71%
8,385 Class A Common Stock
May 25 2022
BUY
Grant, award, or other acquisition
-
2,839 Added 44.63%
3,522 Class A Common Stock
Jan 18 2022
BUY
Grant, award, or other acquisition
-
654 Added 48.92%
683 Class A Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
ENOV
Enovis CORP Industrials
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
Director
OPCH
Option Care Health, Inc. Healthcare
Director
BWB

Barbara W. Bodem

Director
San Diego, CA

Track Institutional and Insider Activities on SYNH

Follow Syneos Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYNH shares.

Notify only if

Insider Trading

Get notified when an Syneos Health, Inc. insider buys or sells SYNH shares.

Notify only if

News

Receive news related to Syneos Health, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYNH